Xcout Intel
LUMINOPIA, INC.
Luminopia, Inc. is a commercial-stage company based in Cambridge, Massachusetts, that pioneered and develops a new class of treatments for neuro-visual conditions.
Subscribe to see LUMINOPIA, INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
LUMINOPIA, INC. at a glance
LUMINOPIA, INC. is a medical devices company headquartered in United States. It has raised at least $38.3M across the 7 funding rounds on record. Its most recent funding round, Series A, raised $16M in June 2023. Xcout tracks 12 named people at LUMINOPIA, INC., including Hank Wu (COO).
LUMINOPIA, INC. leadership
- Hank WuCOO
- Brion RaymondCBO
- Scott XiaoCo-Founder and CEO
- Drew MoweryVP of Commercial Strategy
- Sunny AtwalVP of Engineering
- Stephanie RobertsHead of Market Access
6 more named people on record for LUMINOPIA, INC., with roles, board committees and tenure — see the full roster →
LUMINOPIA, INC. funding rounds
At least $38.3M raised across the 7 rounds on record. The 3 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $16M | 8 named | |
| Series A | $5.7M | 4 named | |
| SEC Form D filing | $11.1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
LUMINOPIA, INC. competitors
A few of LUMINOPIA, INC.'s closest competitors — see the full list of competitors and alternatives →
LumiThera, Inc. is an ophthalmic medical device company that harnesses the power of light to offer a comprehensive approach for detecting and treating eye conditions.
PlenOptika, Inc. is a vision-driven innovation company located in Massachusetts, United States, that provides optical products such as the QuickSee.
Intelon Optics, Inc. is a medical device company headquartered in Lexington, Massachusetts. The firm focuses on the development and commercialization of advanced ophthalmic technology, specifically the Brillouin Optical Scanner System.
Adaptilens, Inc. is an ophthalmic medical device company headquartered near Boston, Massachusetts, focused on developing advanced accommodating intraocular lenses (IOLs). Founded by ophthalmic device inventors, the company aims to restore natural range of vision for cataract patients through innovative lens technologies. It conducts clinical evaluations and secures venture backing to advance its medical device pipeline.
NeuroThera develops a clinical-grade transcranial photobiomodulation platform that delivers near-infrared laser light to targeted brain regions. The company's non-invasive technology aims to treat major neurological and psychiatric conditions, including major depressive disorder, Alzheimer's disease, Parkinson's disease, traumatic brain injury, and stroke recovery.
NeuroGlove, LLC develops a novel medical device designed to treat a variety of neurological and psychological conditions, including stroke, Parkinson's disease, PTSD, traumatic brain injury, anxiety, depression, and insomnia. The company serves patients and healthcare sectors by providing innovative treatment options aimed at transforming healthcare.
Get LUMINOPIA, INC.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on LUMINOPIA, INC. in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- 7 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access